The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 21, 2021

Filed:

Jul. 22, 2016
Applicant:

Hanmi Pharm. Co., Ltd., Hwaseong-si, KR;

Inventors:

Sun Jin Moon, Hwaseong-si, KR;

Cheong Byeol Shin, Hwaseong-si, KR;

Sung Hee Hong, Hwaseong-si, KR;

Dae Jin Kim, Hwaseong-si, KR;

Se Chang Kwon, Hwaseong-si, KR;

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 1/30 (2006.01); A61K 47/60 (2017.01); C07K 14/605 (2006.01); C07K 14/52 (2006.01); C07K 14/59 (2006.01); C07K 14/62 (2006.01);
U.S. Cl.
CPC ...
A61K 47/60 (2017.08); C07K 1/30 (2013.01); C07K 14/52 (2013.01); C07K 14/59 (2013.01); C07K 14/605 (2013.01); C07K 14/62 (2013.01); C07K 2319/30 (2013.01);
Abstract

Provided is a method of preparing a physiologically active polypeptide conjugate, in which a physiologically active polypeptide and a non-peptidyl polymer are linked to each other via a covalent bond. The method is to improve an overall yield of the physiologically active polypeptide conjugate by improving a reaction of the non-peptidyl polymer and the physiologically active polypeptide, and particularly, the method is to prepare a physiologically active polypeptide conjugate in a high yield by performing a two-step reaction through selective precipitation. The preparation method of the present invention is used to produce a non-peptidyl polymer-physiologically active polypeptide conjugate and a physiologically active polypeptide-physiologically active carrier conjugate in a high yield, and therefore, the method may be used in the development of long-acting formulations of various peptide drugs which maintain in vivo activity at a relatively high level and have remarkably increased blood half-life.


Find Patent Forward Citations

Loading…